Supports health care providers prescribe and manage opioids for patients with chronic non-cancer pain through succinct information, with fillable appendices that can be inserted into the patient chart. Provided by the Centre for Effective Practice
The cases in the HARMS Program learning modules are based on real cases and were specifically chosen to illustrate key principles when using urine drug testing in a primary care setting for chronic non-cancer pain.
The cases in the HARMS Program learning modules are based on real cases and were specifically chosen to illustrate key principles when using urine drug testing in a primary care setting for chronic non-cancer pain.
A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian).
A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian).
